date:Jan 22, 2014
s is in dietary supplements and not in food and beverage, said Rolf-Dieter Schwalb, chief financial officer and a member of the managing board, in the Jan. 21 earnings conference call.
According to unaudited results released Jan. 21, DSMs Nutrition business in the full fiscal year had EBITDA of 913 million ($1,236 million), which was up from 793 million in the previous fiscal year. Nutritions net sales for the fiscal year were 4,195 million ($5,680 million), which compared with 3,667 million in